Angioimmunoblastic T-cell lymphoma: Difference between revisions

From IDWiki
(Created page with "== Background == * Subtype of mature peripheral T-cell lymphoma * Previously also known as angioimmunoblastic lymphadenopathy with dysproteinemia, immunoblastic lymphadenopathy, and lymphogranulomatosis X * Accounts for 1 to 2% of non-Hodgkin lymphoma * Derives from follicular T helper (T<sub>FH</sub>) cells == Clinical Manifestations == * Myriad and often non-specific, resulting in delayed diagnoses * Usually advanced stage at diagnosis * Most common symptoms are...")
 
No edit summary
 
Line 17: Line 17:
* May have hypereosinophilia, occasionally have thrombocytopenia
* May have hypereosinophilia, occasionally have thrombocytopenia
* May have false-positive autoimmune tests, including rheumatoid factor and anti-smooth muscle antibodies
* May have false-positive autoimmune tests, including rheumatoid factor and anti-smooth muscle antibodies

=== Prognosis ===

* 5-year survival about 30%

== Further Reading ==

* Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma. ''Blood''. 2017;129(9):1095-1102. doi: [https://doi.org/10.1182/blood-2016-09-692541 10.1182/blood-2016-09-692541]


[[Category:Hematology]]
[[Category:Hematology]]

Latest revision as of 02:30, 10 October 2022

Background

  • Subtype of mature peripheral T-cell lymphoma
  • Previously also known as angioimmunoblastic lymphadenopathy with dysproteinemia, immunoblastic lymphadenopathy, and lymphogranulomatosis X
  • Accounts for 1 to 2% of non-Hodgkin lymphoma
  • Derives from follicular T helper (TFH) cells

Clinical Manifestations

  • Myriad and often non-specific, resulting in delayed diagnoses
  • Usually advanced stage at diagnosis
  • Most common symptoms are constitutional symptoms (fevers, night sweats, weight loss) and lymphadenopathy
  • May have hepatosplenomegaly
  • May have skin lesions which range from urticaria to nodules
  • May get rash after antibiotics
  • Often have elevated LDH, anemia, positive DAT, hypergammaglobulinemia (polyclonal)
  • May have hypereosinophilia, occasionally have thrombocytopenia
  • May have false-positive autoimmune tests, including rheumatoid factor and anti-smooth muscle antibodies

Prognosis

  • 5-year survival about 30%

Further Reading